Gastrointestinal Cancer | Specialty

The OncLive Gastrointestinal Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of gastrointestinal (GI) cancers, including hepatocellular carcinoma, gastric cancer, pancreatic cancer, colorectal cancer, cholangiocarcinoma, esophageal cancer, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in GI cancers.

Dr. Daniel Von Hoff on Combination Treatments for Late Stage Pancreatic Cancer

April 27th 2015

Daniel Von Hoff, MD, the Physician-in-Chief and Director of Translational Research at the Translational Genomics Research Institute (TGen) and a special consult with Baylor University College of Medicine, discuses combination treatments for pancreatic cancer.

FDA Approval Sought for MM-398 in Advanced Pancreatic Cancer

April 27th 2015

A new drug application has been submitted for MM-398 in combination with 5-fluorouracil and leucovorin for patients with metastatic pancreatic cancer following prior treatment with a gemcitabine-based therapy.

FDA Approves Second-Line Ramucirumab for mCRC

April 24th 2015

The FDA has approved second-line ramucirumab in combination with FOLFIRI as a treatment for patients with metastatic colorectal cancer (mCRC) following progression an upfront bevacizumab-containing regimen.

Long-term Aspirin Use Decreases Risk of GI Cancers, Especially Colorectal

April 20th 2015

A recent study joins a body of evidence suggesting that long-term, regular aspirin use is associated with a reduced risk for cancer, with the most dramatic reduction being seen in colorectal cancer incidence.

Oral Fluoropyrimidine TAS-102 in Refractory mCRC

April 16th 2015

Use of Regorafenib in Refractory mCRC

April 16th 2015

Second-Line Therapy for RAS Wild-Type mCRC

April 16th 2015

Choosing Between VEGF and EGFR Targeted Therapy in mCRC

April 16th 2015

Newly Diagnosed mCRC Treatment Goals

April 16th 2015

The Genetic Landscape of Pancreatic Cancer

April 8th 2015

Early Diagnosis Challenging in Pancreatic Cancer

April 8th 2015

Treatment Approaches For Resectable Pancreatic Tumors

April 8th 2015

Treating Borderline Resectable/Locally Advanced Pancreatic Cancer

April 8th 2015

Treating Metastatic Pancreatic Cancer

April 8th 2015

The Role of Clinical Trials

April 8th 2015

Emerging Therapies and Future Treatment Approaches

April 8th 2015

Targeting the Tumor Microenvironment in Treating Pancreatic Cancer

April 8th 2015

Treating Pancreatic Neuroendocrine Tumors

April 8th 2015

Dr. James Fleshman on Minimally Invasive Surgery for Colorectal Cancer

April 8th 2015

James W. Fleshman Jr, MD, from the Department of Surgery and Internal Medicine at Baylor University Medical Center, discusses the surgical management of colorectal cancer.

Colorectal Cancer Management Requires Multidisciplinary Approach

April 7th 2015

In an interview with OncLive, James W. Fleshman Jr, MD, explained how technological advances and a growing commitment to a multidisciplinary approach have impacted the treatment of colorectal cancer.

NEXT PAGE
PREVIOUS PAGE